Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Healthcare Professionals

Bioresorbable Nasal Packing Products

  • Bioresorbable Nasal Packing for FESS

Bioresorbable and Biofragmentable Nasal Packing

Medtronic's high-performance bioresorbable and biofragmentable nasal packing eliminates the need for painful packing removal following FESS. We offer nasal packing products to assist with stenting, bleeding control, wound healing, and antibacterial effectiveness.*

Expand All

bioresorbable and biofragmentable nasal packing

Nasal Packing Performance Without Painful Removal

MeroGel Nasal Packing Results in Fewer Adhesions

Bioresorbable and biofragmentable nasal packing for FESS can help:

  • Control bleeding
  • Prevent adhesions
  • Provide antimicrobial properties*
  • Absorb drainage
  • Aid wound healing
  • Eliminate the need for painful nasal packing removal

The Right Nasal Packing for Your Patient

NovaShield Nasal Packing for FESS

Chitosan-Based Nasal Packing

NovaShield™ nasal packing is made from chitosan, a polymer chemical produced from chitin, a component of the hard external shell of shellfish (e.g., crab, lobster, and shrimp). Chitosan's hemostatic properties have been extensively studied.1-10

Hyaluronic Acid-Based Nasal Packing

MeroGel® and MeroPack® nasal packing use esterified hyaluronic acid (HYAFF®), a naturally occurring constituent of the extracellular matrix that helps keep wounds moist, reduce adhesions, and decrease healing time.11 

Traditional Nasal Packing

View traditional nasal packing in the ENT Product Catalog.

*

Only our NovaShield™ nasal packing product has antibacterial properties. In vitro efficacy is not correlated to the clinical effectiveness.

References

1

Shikani AH, Chahine KA, Alqudah MA. Endoscopically guided chitosan nasal packing for intractable epistaxis. Am J Rhinol Allergy. 2011;25(1):61-63.

2

Kourelis K, Shikani AH. Effectiveness of chitosan-based packing in 35 patients with recalcitrant epistaxis in the context of coagulopathy. Clin Otolaryngol. 2012;37(4):309-313.

3

Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997; 34:21–28.

4

Malette WG, Quigley H, Gaines RD, Johnson ND, Rainer G. Chitosan: a new hemostatic. Ann Thorac Surg.1983; 36:55–58.

5

Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun. 2003; 302:480–483.

6

Dutkiewicz JK. Superabsorbent materials from shellfish waste–a review. J Biomed Mater Res. 2002; 63:373–381.

7

Brandenberg G, Leibrock LG, Shuman R, Malette WG, Quigley H. Chitosan: a new topical hemostatic agent for diffuse capillary bleeding in brain tissue. Neurosurgery. 1984; 15:9–13.

8

Hirano S, Zhang M, Nakagawa M, Miyata T. Wet spun chitosan-collagen fibers, their chemical N-modifications, and blood compatibility. Biomaterials. 2000; 21:997–1003.

9

Belman A, Daya M, Steve M, Worley J. From the battlefield to the street—experience of a suburban fire/EMS agency with chitosan dressing. 2006; Touch Briefings: Emergency Medicine & Critical Care Review.

10

Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma. 2006; 60:655-658.

11

Berlucchi M, Castelnuovo P, Vincenzi A, Morra B, Pasquini E. Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study. Eur Arch Otorhinolaryngol. 2009; 266(6):839-845.

HYAFF® is a registered trademark of Anika Therapeutics SRL.

why use nasal packing?

*

Only our NovaShield™ nasal packing product has antibacterial properties. In vitro efficacy is not correlated to the clinical effectiveness.